Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 21.86
-0.45 (-2.02%)
Oct 30, 2026, 3:04 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 19.31 billion as of October 30, 2026. It is the 5,182nd most valuable company in the world and the 789th biggest in China. Its market cap has decreased by 1.93% in one year.
Market Cap
19.31B
Enterprise Value
20.99B
Revenue
1.53B
Global Rank
Country Rank
#789 China
PE Ratio
49.70
ChartMarket Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 19.31B, an increase of 558.96%. That is a compound annual growth rate of 12.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 19.31B | 22.12% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 21.92B |
| Apeloa Pharmaceutical Co.,Ltd | 21.91B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.47B |
| Tasly Pharmaceutical Group | 20.33B |
| Guangdong Zhongsheng Pharmaceutical | 20.08B |
| Jilin Aodong Pharmaceutical Group | 19.22B |
| Walvax Biotechnology | 18.41B |
| Joincare Pharmaceutical Group Industry | 18.20B |